A Symposium on Diabetes, Obesity, Atherosclerosis and Cardiovascular

Renowned speakers from China, UK, USA and Hong Kong SAR, will focus on different aspects in relation to the management of diabetes, obesity, atherosclerosis and cardiovascular in the general practice setting.

This must-attend annual symposium is expecting an attendance of more than 600 delegates. The symposium programme will feature the highest quality content and is designed to facilitate extensive networking.

HKFRDD Session

• How good is HbA_1c for diagnosing diabetes (Nick Wareham, UK)

• Cardiovascular risk factors – a local landscape (Bernard Cheung, Hong Kong SAR)

• Chronic disease management and shared care – from research to policies
  (Linda Yu, Hong Kong SAR)

• The cost effectiveness of interventions and willingness to pay for preventing diabetes
  (Ping Zhang, USA)

HKASO Session

• Obesity and metabolic syndrome in developing countries (Anoop Misra, India)

• The role of psychosocial factors in the pathogenesis of obesity (Gary Ko, Hong Kong SAR)

• Types of fat and energy homeostasis (Peng Li, China)

• Non-alcoholic fatty liver disease (Vincent Wong, Hong Kong SAR)

HKAS Session

• The evidence of comprehensive lipid management – reducing cardiovascular risk in diabetes
  (John Betteridge, UK)

• The role of ARBs – what are the pros and cons? (Herman Haller, Germany)

• Effects of drugs on postprandial hyperlipidaemia (Shizuya Yamashita, Japan)

• Reducing cardiovascular risk: what foods are really functional? (June Chan, Hong Kong SAR)